Hemmerly Nicholas H. 4
4 · JUPITER NEUROSCIENCES, INC. · Filed Jun 4, 2026
Research Summary
AI-generated summary of this filing
Jupiter Neurosciences Director Nicholas Hemmerly Receives Award
What Happened
Nicholas H. Hemmerly, a director of Jupiter Neurosciences, reported a grant/award on 2026-06-02 of 100,000 derivative securities (reported at $0.00). The filing identifies these as options granted under the company's 2025 Equity Incentive Plan; no cash was paid as part of the reported acquisition.
Key Details
- Transaction date: 2026-06-02; Form 4 filed: 2026-06-04 (filed within the standard 2-business-day window).
- Transaction type: Award/Grant (derivative securities).
- Amount: 100,000 derivative securities; reporting price shown as $0.00 (total reported value $0).
- Vesting: Options vest over three years commencing September 2, 2026, in equal quarterly installments, subject to continued service (per footnote).
- Shares owned after transaction: Not specified in the provided filing details.
- Footnote: Grants made under the Issuer's 2025 Equity Incentive Plan; vesting schedule described above.
Context
This was an equity award (options) rather than an open-market purchase or sale. Awards are typically part of compensation and are subject to vesting conditions, so they do not represent immediate share purchases or liquidity events. The filing appears timely; no 10b5-1 plan, tax withholding, or immediate exercise/sale was reported.
Insider Transaction Report
- Award
Stock Option
[F1]2026-06-02+100,000→ 100,000 totalExercise: $0.28Exp: 2036-06-02→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The options were granted under the Issuer's 2025 Equity Incentive Plan. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued service through each vesting date.